Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model

A combination of LC and MS was applied to an isogenic breast tumor metastasis model to identify proteins associated with a cellular phenotype. Chromatofocusing followed by nonporous‐RP‐HPLC/ESI‐TOF MS was applied to cell lysates of a pair of monoclonal cell lines from the human breast carcinoma cell line MDA‐MB‐435 that have different metastatic phenotypes in immune‐compromised mice. This method was developed to separate proteins based on pI and hydrophobicity. The high resolution and mass accuracy of ESI‐TOF measurements provided a good correlation of theoretical MW and experimental Mr values of intact proteins measured in mass maps obtained in the pH range 3.8–6.4. The isolated proteins were digested by trypsin and analyzed by MALDI‐TOF MS, MALDI‐QIT‐TOF MS, and monolith‐based HPLC/MS/MS. The unique combination of the techniques provided valuable information including quantitation and modification of proteins. We identified 89 selected proteins, of which 43 were confirmed as differentially expressed. Metastasis‐associated proteins included galectin‐1, whereas annexin I and annexin II were associated with the nonmetastatic phenotype. In this study, we demonstrate that combining a variety of MS tools with a multidimensional liquid‐phase separation provides the ability to map cellular protein content, to search for modified proteins, and to correlate protein expression with cellular phenotype.

[1]  Yan Li,et al.  Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy , 2004, Nature.

[2]  Yun-ping Zhu,et al.  Identification of metastasis‐associated proteins by proteomic analysis and functional exploration of interleukin‐18 in metastasis , 2003, Proteomics.

[3]  A. Baldini,et al.  Mapping on human and mouse chromosomes of the gene for the beta-galactoside-binding protein, an autocrine-negative growth factor. , 1993, Genomics.

[4]  S. Goodison,et al.  Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Maria D Person,et al.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration , 2003, Oncogene.

[6]  Allison Jones,et al.  cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.

[7]  W. Parson,et al.  Preparation and evaluation of packed capillary columns for the separation of nucleic acids by ion-pair reversed-phase high-performance liquid chromatography. , 2000, Journal of chromatography. A.

[8]  P. Steeg,et al.  Basic and Translational Advances in Cancer Metastasis: Nm23 , 2003, Journal of bioenergetics and biomembranes.

[9]  S. Goodison,et al.  Detection of differentially expressed genes in an isogenic breast metastasis model using RNA arbitrarily primed-polymerase chain reaction coupled with array hybridization (RAP-array). , 2004, The American journal of pathology.

[10]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[11]  S. Goodison,et al.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.

[12]  T. Veenstra,et al.  What to do with “one‐hit wonders”? , 2004, Electrophoresis.

[13]  S. Deutscher,et al.  Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. , 2000, Cancer research.

[14]  G. Guiochon,et al.  Study of the mass transfer kinetics in a monolithic column. , 2003, Journal of chromatography. A.

[15]  M. Paul-Clark,et al.  The annexin-1 knockout mouse: what it tells us about the inflammatory response. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[16]  J. Rodrigo,et al.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.

[17]  P. Hall,et al.  Do septins have a role in cancer? , 2005, British Journal of Cancer.

[18]  F. Miller,et al.  Identification of low molecular weight proteins isolated by 2-D liquid separations. , 2004, Journal of mass spectrometry : JMS.

[19]  S. Parus,et al.  Comparison of the capabilities of liquid isoelectric focusing-one-dimensional nonporous silica reversed-phase liquid chromatography-electrospray ionization time-of-flight mass spectrometry and liquid isoelectric focusing-one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis mass , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[20]  R. Taichman,et al.  The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer. , 2005, Cancer research.

[21]  Y. Ohe,et al.  Human spleen histone H1. Isolation and amino acid sequences of three minor variants, H1a, H1c, and H1d. , 1989, Journal of biochemistry.

[22]  S. Goodison,et al.  Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Kan Zhu,et al.  Two-dimensional liquid separations-mass mapping of proteins from human cancer cell lysates. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  F. Švec Preparation and HPLC applications of rigid macroporous organic polymer monoliths. , 2004, Journal of separation science.

[25]  Milton L. Lee,et al.  Preparation and evaluation of poly(polyethylene glycol methyl ether acrylate-co-polyethylene glycol diacrylate) monolith for protein analysis. , 2005, Journal of chromatography. A.

[26]  R. Hughes Galectins as modulators of cell adhesion. , 2001, Biochimie.

[27]  Hiroshi Kobayashi,et al.  How to utilize the true performance of monolithic silica columns. , 2004, Journal of separation science.

[28]  F. Miller,et al.  Chromatofocusing nonporous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates: a novel two-dimensional liquid chromatography/mass spectrometry method. , 2001, Rapid communications in mass spectrometry : RCM.

[29]  F. Švec,et al.  Photopolymerized monolithic capillary columns for rapid micro high-performance liquid chromatographic separation of proteins. , 2004, Journal of chromatography. A.

[30]  C. Huber,et al.  High-performance liquid chromatography-electrospray ionization mass spectrometry of single- and double-stranded nucleic acids using monolithic capillary columns. , 2000, Analytical chemistry.

[31]  G. Rabinovich Galectin-1 as a potential cancer target , 2005, British Journal of Cancer.

[32]  J. Yates,et al.  Shotgun proteomics of Methanococcus jannaschii and insights into methanogenesis. , 2004, Journal of proteome research.

[33]  J. Votaw,et al.  Silencing of CXCR4 blocks breast cancer metastasis. , 2005, Cancer research.

[34]  K. Gevaert,et al.  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.

[35]  G. Bevilacqua,et al.  NM23 gene expression in human breast carcinomas: Loss of correlation with cell proliferation in the advanced phase of tumor progression , 1997, International journal of cancer.

[36]  Ningli Li,et al.  The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis , 2006, Molecular Pharmacology.

[37]  C. Perou,et al.  Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.

[38]  F. Miller,et al.  A two‐dimensional liquid‐phase separation method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification , 2004, Proteomics.

[39]  K. Kayser,et al.  Galectins-1 and -3 and their ligands in tumor biology , 1999, Journal of Cancer Research and Clinical Oncology.

[40]  E. Postel Multiple Biochemical Activities of NM23/NDP Kinase in Gene Regulation , 2003, Journal of bioenergetics and biomembranes.

[41]  K. Nakanishi,et al.  Monolithic silica columns with various skeleton sizes and through-pore sizes for capillary liquid chromatography. , 2002, Journal of chromatography. A.

[42]  B. Subramanian,et al.  A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionation. , 2003, Analytical chemistry.

[43]  Rong Zeng,et al.  From Proteomic Analysis to Clinical Significance , 2004, Molecular & Cellular Proteomics.

[44]  J. Gillette,et al.  Annexin 2 expression is reduced in human osteosarcoma metastases , 2004, Journal of cellular biochemistry.

[45]  E. Solito,et al.  Annexin 1: more than an anti-phospholipase protein , 2004, Inflammation Research.

[46]  A. Burlingame,et al.  Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Goodison,et al.  Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements. , 2005, Cancer genetics and cytogenetics.

[48]  D. Piwnica-Worms,et al.  CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.

[49]  E. Rapoport,et al.  Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer , 2005, Breast Cancer Research and Treatment.